drugset / Trial / NCT05750056

Dose Systemic Lidocaine Improve the Quality of Recovery After Colorectal Endoscopic Submucosal Dissection

NCT05750056

Phase 4 Completed 234 enrolled Fujian Provincial Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Endoscopic submucosal dissection (ESD) is a common procedure that requires a long procedural time. Procedure Sedation is commonly provided to alleviate patients' discomfort and facilitate the implementation of procedures. We conducted a prospective study to determine the effect of intravenous infusion of lidocaine in the cognitive domain of the postoperative quality of recovery scale on day 3 after ESD.

Timeline

Start
2023-02-24
Primary completion
2024-03-29
Completion
2024-04-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 2 mg/kg Intravenous
Background Propofol Small molecule 1 mg/kg Intravenous
Background Sufentanil Other / unclassified 0.1 ug/kg

Indications

No indication recorded.